Definium Therapeutics, Inc. — Key Metrics
3 years of history · ending 2023-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Expense Ratios
Working Capital Analysis
Valuation Multiples
Cash-Flow Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
EPS (Diluted)
$-2
Book Value Per Share
$2
Free Cash Flow Per Share
$-2
Cash Per Share
$3
Revenue Per Share
$0
OCF Per Share
$-2
Return on Equity
-83.6%
Return on Assets
-65.0%
Return on Invested Capital
-57.6%
Debt to Equity
0.18
Current Ratio
3.22
Quick Ratio
3.22
Asset Turnover
0.03
R&D / Revenue
1117.6%
Working Capital
$72M
Net Current Asset Value
$57M
Invested Capital
$92M
OCF / Net Income
0.67
FCF / Net Income
0.67
Accruals Ratio (Sloan)
-25.2%
Net Debt
$-86M
Net Debt / EBITDA
0.94
Interest Coverage
-102.03
Cash Coverage
-69.96
Tangible Common Equity
$58M
TCE / Total Assets
46.3%
Goodwill / Total Assets
16.0%
NOPAT
$-74M
Cash ROIC
-50.0%
WC / Revenue
1535.7%
Reinvestment Rate
-0.3%
Asset Growth vs Revenue Growth
-238.7%
Book Value 5Y CAGR
—
Stock Price (FY-end)
$4
Market Cap
$143M
P/E Ratio
-1.50
P/S Ratio
30.73
P/B Ratio
1.83
P/TB Ratio
2.48
P/OCF Ratio
-2.23
P/FCF Ratio
-2.23
FCF Yield
-44.9%
Shares Variation (YoY)
26.9%
Beta (5Y)
1.33
Cost of Equity
11.1%
Cost of Debt (after tax)
5.1%
WACC
10.6%
ROIC - WACC Spread
-68.2%
52W High
$5
52W Low
$2
Trailing Return 1M
13.0%
Trailing Return 6M
2.5%
Trailing Return 1Y
71.0%
Trailing Return 5Y
510.0%
F-Score (Piotroski)
2.00
Z-Score (Altman)
-3.17
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.